• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿霉素与甲氨蝶呤联合对小鼠L1210白血病的细胞毒性

Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice.

作者信息

Valeriote F, Vietti T, Coulter D

出版信息

J Natl Cancer Inst. 1980 Apr;64(4):801-5.

PMID:6928994
Abstract

The combination of adriamycin and methotrexate was found in mice to be synergistic in cytotoxicity to L1210 leukemia cells for a range of time intervals between the two agents. Cytotoxicity for normal hematopoietic stem cells was less than additive. Spleen colony assays were used to quantitate both cell populations. Increase in life-span assays yielded similar results. Also, the extent of synergy was dependent on the dose of adriamycin only.

摘要

在小鼠实验中发现,阿霉素与甲氨蝶呤联合使用时,在两种药物之间的一系列时间间隔内,对L1210白血病细胞具有细胞毒性协同作用。对正常造血干细胞的细胞毒性小于相加作用。脾集落试验用于定量这两种细胞群体。生存期延长试验得出了类似的结果。此外,协同程度仅取决于阿霉素的剂量。

相似文献

1
Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice.阿霉素与甲氨蝶呤联合对小鼠L1210白血病的细胞毒性
J Natl Cancer Inst. 1980 Apr;64(4):801-5.
2
The enhanced cytotoxicity of combinations of 1-beta-D-arabinofuranosylcytosine and methotrexate.1-β-D-阿拉伯呋喃糖基胞嘧啶与甲氨蝶呤联合使用时增强的细胞毒性。
Cancer Res. 1975 Jun;35(6):1555-8.
3
Doxorubicin and ricin, a strongly synergistic combination in mouse leukemia.
Cancer Treat Rep. 1980;64(12):1375-8.
4
Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.[SP-4-3-(R)]-[1,1-环丁烷二羧酸根合(2-)](2-甲基-1,4-丁二胺-N,N')铂(CI-973, NK121)与标准药物联合用于体内抗小鼠肿瘤的化疗。
Cancer Res. 1994 Aug 15;54(16):4412-8.
5
Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia.
Cancer Treat Rep. 1981 Nov-Dec;65(11-12):1049-53.
6
Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.VM-26和VP-16-213对L1210白血病细胞和造血干细胞的细胞毒性动力学
Cancer Treat Rep. 1978 Sep;62(9):1313-20.
7
Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia.甲氨蝶呤与长春新碱对小鼠L1210白血病的时间依赖性协同作用。
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1889-94.
8
Effects of combined treatment of L1210 leukemia with adriamycin and pustulan.
Arch Immunol Ther Exp (Warsz). 1981;29(6):703-10.
9
Chemotherapy of L1210 leukemia with 5-azacytidine in combination with vincristine, adriamycin, or beta-cytosine arabinoside.用5-氮杂胞苷联合长春新碱、阿霉素或阿糖胞苷治疗L1210白血病。
J Natl Cancer Inst. 1981 Dec;67(6):1283-8.
10
Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.阿霉素与环磷酰胺联合用于L1210白血病的化疗
Cancer Res. 1977 Mar;37(3):678-83.